New CRISPR Technology Offers Unrivaled Control of Epigenetic Inheritance
|
|
0
|
262
|
May 26, 2022
|
Pharmacovigilance analysis of reports of sexual dysfunction associated with finasteride use: Implications for the post-finasteride syndrome. 2022
|
|
4
|
461
|
May 22, 2022
|
YouthBio CEO: The time is right to develop epigenetic reprogramming therapies
|
|
0
|
246
|
May 18, 2022
|
CRISPR technologies for precise epigenome editing
|
|
2
|
292
|
May 18, 2022
|
Finasteride inhibits epinephrine synthesis in humans: implication for sexual dysfunction, Melcangi et al. 2022
|
|
8
|
792
|
May 17, 2022
|
Vascular, Neurologic and Hormonal Abnormalities in Men with Persistent Sexual Dysfunction After Discontinuation of Finasteride: Carlisle et al., 2022
|
|
17
|
925
|
May 13, 2022
|
Researchers Use CRISPR to Reset Anxiety, Alcohol Use Disorder
|
|
0
|
275
|
May 8, 2022
|
Gene Discovery Allows the Production of Inner or Outer Ear Hair Cells (Northwestern University)
|
|
0
|
187
|
May 8, 2022
|
Team uses MRI to image epigenetics in brain
|
|
4
|
534
|
May 4, 2022
|
AI-designed protein can awaken silenced genes one-by-one
|
|
1
|
318
|
May 3, 2022
|
Rare genetic disease ADNP Syndrome to be cured within 3 years
|
|
0
|
279
|
May 3, 2022
|
Scientists Discover Genetic Cause of Lupus
|
|
0
|
205
|
May 2, 2022
|
MIT Scientists Develop New Regenerative Drug That Reverses Hearing Loss
|
|
4
|
326
|
April 30, 2022
|
Recovery of penile fibrosis, is it possible?
|
|
10
|
1540
|
April 28, 2022
|
DHT inhibitors reduce sperm motility & fertility, Propecia-induced spermatogenic failure
|
|
10
|
36980
|
April 21, 2022
|
Clinical Trial for new ED drug targeting Dopamine
|
|
0
|
394
|
April 18, 2022
|
Drug-related sexual dysfunction issues among patients under treatment or previously exposed to SSRIs, 2022
|
|
2
|
348
|
April 17, 2022
|
Newborns experience SSRI withdrawal
|
|
2
|
319
|
April 12, 2022
|
Hypermethylation of ERα & Smooth Muscle Cells
|
|
1
|
349
|
April 11, 2022
|
The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption
|
|
22
|
3210
|
June 28, 2019
|
Link identified between inflammation and brain fog
|
|
15
|
1101
|
February 28, 2022
|
Post-Finasteride Syndrome: Current Views and Where do we Stand? (Ghadah I Alhetheli et al)
|
|
22
|
1321
|
February 11, 2022
|
Non-cell autonomous disruption of nuclear architecture as a potential cause of COVID-19 induced anosmia
|
|
0
|
218
|
February 7, 2022
|
Androgen Receptor upregulation for receptor resensitization
|
|
6
|
827
|
February 1, 2022
|
Up to 15% finasteride side effects and not 2% and 0,3% to 2,1% permanent side effects
|
|
1
|
434
|
January 31, 2022
|
CIALIS increases or decreases the androgen receptor?
|
|
5
|
624
|
January 31, 2022
|
An article about brain fog and "chemo brain"
|
|
0
|
291
|
January 28, 2022
|
Prolactin and low vitamin D as autoimmune disease biomarkers
|
|
16
|
16223
|
January 28, 2022
|
(Study) Neurosteroid Levels in PFS patients
|
|
49
|
26698
|
January 26, 2022
|
Androgens increase excitatory neurogenic potential in human brain organoids
|
|
3
|
370
|
January 26, 2022
|